Anti-Amyloid Therapy

So far, nothing has proven to be clinically effective and safe for widespread use. The only exception is a drug called adjucanamab which was studied in global phase three studies that got stopped early. It's extremely likely that even if anti-amyloid therapies are successful, they won't be the last word in therapy. They will probably only have modest effects at slowing progression or delaying onset. We absolutely need other targets.